112
Participants
Start Date
April 30, 2006
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
Tenofovir disoproxil fumarate (tenofovir DF; TDF)
300-mg tablet QD
Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF)
FTC 200 mg/TDF 300 mg fixed-dose combination (FDC) tablet QD
Entecavir (ETV)
0.5-mg or 1-mg tablet QD
TDF placebo
Placebo to match TDF QD
FTC/TDF placebo
Placebo to match FTC/TDF QD
ETV placebo
Placebo to match ETV QD
Chang-Gung Memorial Hospital, Taipei
Chang Gung Memorial Hospital - Kaohsiung, Kaoshiung Hsien
Mt. Sinai School of Medicine/ Mt. Sinai Medical Center, New York
Columbia Presbyterian Medical Center, New York
Cathay General Hospital, Taipei
"General Hospital of Athens Ippokratio", Athens
Hopital Conception, Marseille
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Berlin
Metropolitan Research, Fairfax
Hospital General Universitario Gregorio Maranon, Madrid
Policlinico Universitario, Udine
University of Miami, Center for Liver Diseases, Miami
Marmara Universitesi School of Medicine, Istanbul
Ege Universitesi Tip Fakultesi Hastanesi, Izmir
Universita de Padova, Padua
Hospital Universitario y Politecnico la Fe, Valencia
Henry Ford Hospital and Health System, Detroit
Johannes Gutenberg-Universitat, Mainz
Rush Presbyterian - St. Luke's Medical Center, Chicago
Universitat Heidelberg, Heidelberg
National Cheng Kung University Hospital, Tainan City
Pfleger Liver Institute, Los Angeles
California Pacific Medical Center Research Institute, San Francisco
Virginia Mason Medical Center, Seattle
National University Hospital Dept. of Gastroenterology & Hepatology, Singapore
Singapore General Hospital, Singapore
Tan Tock Seng Hospital, Singapore
Changi General Hospital, Singapore
Heritage Medical Research Clinic, Calgary
Vancouver General Hospital, Vancouver
The Gordon & Leslie Diamond Centre, Vancouver
Toronto General Hospital, Toronto
Wojewodzki Szpital Specjalistyczny im Dluskeigo, Bialystok
Wojewodzki Szpital Obserwacy, Bydgoszcz
Wojewodzki Szpital Zakazny, Warsaw
Hospital General Universitari Vall d'Hebron, Barcelona
Hospital Clinic i Provincial de Barcelona (HCPB), Barcelona
Hospital Universitario de Bellvitge, Barcelona
Lead Sponsor
Gilead Sciences
INDUSTRY